This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Get instant access to our comprehensive guide and: Identify high-value opportunities for generic competition and biosimilar development Stay ahead of the curve with our expert analysis of upcoming patent expirations Develop a winning strategy to protect your brand and maintain market share Download your copy now and take control of your company's future (..)
Download Issue PDF Articles in this issue Bolstering Health Technology Assessment With the Help of AI Changing the PAP Model Building Intelligent Pharma Supply Chain Management with Real-World Data Policy Whiplash? or the Otsuka Patient Assistance Foundation, Inc.
link] Download Issue PDF Download RIS Articles in this issue Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Accessed June 30, 2025. February 25, 2025. Accessed June 30, 2025.
ASCO 2025: insights on NALIRIFOX use in metastatic pancreatic ductal adenocarcinoma from the NAPOLI-3 trial. Pharmacy Times. June 5, 2025. Accessed June 23, 2025.
Reports Prescriber Opinions on Biosimilars in Immunology Data Insights The gold standard of business intelligence. Please check your inbox to download the Whitepaper. Reports Prescriber Opinions on Biosimilars in Immunology Data Insights The gold standard of business intelligence. You will receive an email shortly.
link] Ewart L, Apostolou A, Briggs SA, et al. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med (Lond). 2022;2(1):154.
Health Aff Sch. 2024;2(4):qxae035. doi:10.1093/haschl/qxae035 Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: a review. Medicina (Kaunas). 2019;55(7):327.doi:10.3390/medicina55070327
Acalabrutinib plus bendamustine and rituximab may become new standard care for untreated MCL. Cancer Therapy Advisor. June 21, 2024. Accessed March 16, 2025.
link] Download Issue PDF Download RIS Articles in this issue Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. November 7, 2022.
0000104 Download Issue PDF Download RIS Articles in this issue The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices Blujepa From GSK Educate Patients About Safe Medication Disposal Pharmacist Spotlight: Callie Paine, PharmD Is There a Marketplace for Mail Order? PLOS Digit Health. 2022;1(10):e0000104.
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.
2022.02.005 Download Issue PDF Download RIS Articles in this issue Pharmacies Need Strategies to Improve Health Care Access Product News for June 2025 Pharmacy Policy Updates for June 2025 Pharmacist Spotlight: Shivani Mehta, PharmD Do We Really Pay More for Prescription Drugs in the United States? J Am Pharm Assoc (2003).
link] Download Issue PDF Download RIS Articles in this issue Blujepa From GSK Educate Patients About Safe Medication Disposal Pharmacist Spotlight: Callie Paine, PharmD Is There a Marketplace for Mail Order? United States Drug Enforcement Administration. Accessed June 6, 2025. Drug disposal: drug take-back options.
Clin Dermatol. 2016;34(5):571-581. doi:10.1016/j.clindermatol.2016.05.006 2016.05.006 What to look for: ABCDEs of melanoma. American Academy of Dermatology. Accessed June 5, 2025.
link] Download Issue PDF Download RIS Articles in this issue Pharmacists Can Provide Travel Health Tips for Patients Is Fluoride Friend or Foe? Accessed April 28, 2025. Measles outbreak case definition. Texas Department of State Health Services. Updated April 10, 2025. Accessed April 28, 2025.
Misconceptions about biosimilars include doubts about their safety, efficacy, and risks associated with switching from reference biologics. Biosimilars extend beyond cost savings, improving access to essential treatments, especially in underserved populations. 2 Misconceptions About BiosimilarsBiosimilars are the same as generics.
Download Issue PDF Download RIS Articles in this issue Evaluation of a Pharmacy-Delivered Oncofertility Intervention Pharmacy Leadership in the Future of Oncology Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
The publication showcased not only the impact of CHAMP services but also the interdisciplinary growth and meaningful reflection of the students involved. It was a deeply rewarding experience as both a researcher and an educator.
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.
Download Issue PDF Articles in this issue Bolstering Health Technology Assessment With the Help of AI Changing the PAP Model Building Intelligent Pharma Supply Chain Management with Real-World Data Policy Whiplash? Haub School of Business.
REFERENCE Soefje SA. 505(b)(2) drugs: new chaos for infusion centers. Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR.
link] Download Issue PDF Download RIS Articles in this issue Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. trillion economic impact in 2020. September 9, 2019.
link] Bosnic-Anticevich S, Bakerly ND, Chrystyn H, Hew M, van der Palen J. Advancing digital solutions to overcome longstanding barriers in asthma and COPD management. Patient Prefer Adherence. 2023;17:259-272.
N Engl J Med. 2025;392(5):427-437. doi:10.1056/NEJMoa2410027 Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391(2):109-121.
doi:10.1136/bmjresp-2023-002141 Download Issue PDF Download RIS Articles in this issue Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia? Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11(1):e002141.
link] Download Issue PDF Download RIS Articles in this issue Pharmacy Policy Updates for June 2025 Pharmacist Spotlight: Shivani Mehta, PharmD Do We Really Pay More for Prescription Drugs in the United States? Koseff A, Hwang K. Gavin Newsom says these middlemen drive up drug prices. He’s got a new plan to fix it. Cal Matters.
For effective patient care, we need smart people to design workflows for operationalizing 505(b)(2) drugs, integrating the next biosimilar we have to stock, and managing the compounding of a new hazardous drug. We need people to coordinate and track prior authorizations, write persuasive appeal letters, and keep patients updated.
doi:10.5688/ajpe8920 Download Issue PDF Download RIS Articles in this issue Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School Pharmacists Can Provide Travel Health Tips for Patients Is Fluoride Friend or Foe? Chesnut R, Anderson GW, Buncher O, Dietrich MA, Rosenberg JM, Ross LJ. Am J Pharm Educ.
Literature suggests a 3% difference in the rate of FN between CSF agents filgrastim (Neupogen; Amgen)/filgrastim biosimilars and pegfilgrastim (Neulasta; Amgen)/pegfilgrastim biosimilars. Utilizing colony-stimulating factors (CSFs) decreases the incidence of severe FN. HOPA has selected 4.0 Additional information is available here.
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review. Ment Health Clin. 2023;13(5):225-232. doi:10.9740/mhc.2023.10.225
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.
Accessed January 20, 2025. link] Short L, Holt RA, Cullis PR, Evgin L. Direct in vivo CAR T cell engineering. Trends Pharmacol Sci. 2024;45(5):406-418. doi:10.1016/j.tips.2024.03.004
link] Download Issue PDF Articles in this issue Bolstering Health Technology Assessment With the Help of AI Changing the PAP Model Building Intelligent Pharma Supply Chain Management with Real-World Data Policy Whiplash? About the Author Jeff Webber is Chief Technology Officer at Intelliguard. References 1. FDA at a Glance.
Psychedelic Pharmacists Association is working to promote, establish the role of the pharmacist in psychedelic-assisted therapy. Pharmacy Times. January 17, 2024. Accessed May 16, 2025. About the PPA. Psychedelic Pharmacists Association. Accessed May 16, 2025.
CMS should draw on lessons from previous transitions, including biosimilar coverage rollouts and site-of-care policy shifts, to avoid known implementation pitfalls. Department of Health and Human Services), https ://www.cms.gov/Medicare/Prescription-Drug- Coverage/PrescriptionDrugCovContra/Downloads/Part-D-Benefit-Manual-Chapter-6.pdf.
link] Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug expenditures and projections for 2024. Am J Health Syst Pharm. 2024;81(14):583-598.
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.
Submit Download Issue PDF Download RIS Articles in this issue Spring 2025 Quiz: Test Your Pharmacy Knowledge! Image credit: Orawan | stock.adobe.com Which of the following drug classes is included in the Expert Consensus Decision Pathway guideline–directed medical therapy for heart failure?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content